Vice President, Translational Science, EnBiotix
Proventa International will be gathering over 100 C-Level Directors from a mix of emerging to large Pharmaceutical, Biotechnology & Academic/Research Institutions to help solve their key strategic challenges in the area of Bioinformatics.Register Now
The Bioinformatics Roundtable Discussions Strategy Meeting is free to attend for qualified end-users. These include Senior Executives of Biomedical Informatics, Scientific Computing and Digital Health (from medium to large Pharma, Biopharma and Biotech players) who aim to accelerate discovery, translational, clinical, CMC, and regulatory programs across the R&D pipeline, as well as thought leaders from Academia and regulatory authorities.
Thought leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
– R&D IT, Computational Biology/Sciences, Cloud Computing, Next-Gen Sequencing informatics, Clinical Research and Translational Informatics, Clinical Genomics, Data & Storage Management, Data Computing, Data Visualization & Exploration.
Those who do not qualify for complimentary passes, including vendors, exchanges, consultancies and other service providers, can apply here.
Vice President for Research, Windber Research Institute
Vice President, Data Science and IT, H3 Biomedicine
Before coming to H3 Biomedicine, Dr. Yu spent 12 years with AstraZeneca’s research and development unit, helping to build and deliver the multinational pharmaceutical company’s oncology bioinformatics capabilities. During her time there, she provided bioinformatics support to key areas of oncology drug discovery programs, including target identification and patient selection initiatives.
Lihua received a B.E. in biomedical engineering and a B.E. in automation from Tsinghua University in Beijing. She earned her master of engineering from Tsinghua University and a Ph.D. from Boston University. Lihua is a two-time recipient of the AstraZeneca Global Scientific and Technical Achievement Award, and is an active member of the American Association for Cancer Research. She is a recipient of PharmaVoice 100, 2015.
Global Head of Computer-Aided Drug Discovery, Novartis
José joined Novartis in 2010. Previously he had been with the Schering-Plough Research Institute and Merck Research Laboratories in Kenilworth, NJ, USA for 10 years where he had increasing responsibilities in the CADD group. His scientific fields of expertise within computational chemistry
comprise molecular thinking, modeling, ab initio calculations, molecular recognition, QM-MM methods, solvation and structure-based drug design. José is passionate about drug discovery.
He received his Ph.D. in Chemistry from the National University of Córdoba, Argentina. He joined Prof. Tony Hopfinger’s group in the College of Pharmacy at the University of Illinois at Chicago as a Postdoctoral Fellow.
Executive Director, Genome Sciences & Technologies, Pfizer
Head, Translational Medicine Biostatistics / Head, Nonclinical Efficacy and Safety Biostatistics, Sanofi
SponsorsSee All Of Our Sponsors
Roundtable Discussion Format, Bioinformatics Strategy Meeting Europe 2015
The Westin Boston Waterfront
425 Summer St, Boston, MA 02210